Trial Profile
An Open-label Pharmacokinetic Drug Interaction Study of Folic Acid and 250 Mcg NGM/35 Mcg E E (ORTHO-CYCLEN) in Healthy Women.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/norgestimate (Primary) ; Folic acid
- Indications Congenital abnormalities; Pregnancy
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 30 Jun 2008 New trial record